Market Overview

Esperion Therapeutics (NASDAQ: ESPR)

37.17 0.00 (0.00%)

Analyst Ratings

DateResearch FirmActionCurrentPT
8/17/20B of A SecuritiesMaintainsBuy55.0
8/11/20Credit SuisseDowngradesNeutral45.0
5/07/20JefferiesMaintainsBuy70.0
4/16/20Northland Capital MarketsMaintainsMarket Perform42.0
4/01/20B of A SecuritiesInitiates Coverage OnBuy50.0
3/17/20CitigroupUpgradesBuy
2/28/20JP MorganMaintainsNeutral47.0
2/24/20NeedhamMaintainsStrong Buy158.0
2/24/20Northland SecuritiesDowngradesMarket Perform
2/14/20CitigroupDowngradesNeutral82.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter